Lu Gao

Lu Gao

Auto-generated profile, based on publicly available information

Lu Gao

Department of Breast Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, No. 1 Shuaifuyuan, Dongcheng District, Beijing, 100730, China

Research Focus & Metrics

Academic Career Length

36Years (1991-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 April 2021 in Briefings in Bioinformatics
Verified
Journal Article
Open access
PDF file
ZWZihao Wang
Zihao Wang
YWYaning Wang
Yaning Wang
TYTianrui Yang
Tianrui Yang
HXHao Xing
Hao Xing
YWYuekun Wang
Yuekun Wang
WMWenbin Ma
Wenbin Ma
Glioblastoma (GBM) is the most malignant and lethal intracranial tumor, with extremely limited treatment options. Immunotherapy has been widely studied in GBM, but none can significantly prolong the overall survival (OS) of patients without selection. Considering that GBM cancer stem cells (CSCs) play a non-negligible role in tumorigenesis and chemoradiotherapy resistance, we proposed a novel stemness-based classification of GBM and screened out certain population more responsive to immunotherapy. The one-class logistic regression algorithm was used to calculate the stemness index (mRNAsi) of 518 GBM patients from The Cancer Genome Atlas (TCGA) database based on transcriptomics of GBM and pluripotent stem cells. Based on their stemness signature, GBM patients were divided into two subtypes via consensus clustering, and patients in Stemness Subtype I presented significantly better OS but poorer progression-free survival than Stemness Subtype II. Genomic variations revealed patients in Stemness Subtype I had higher somatic mutation loads and copy number alteration burdens. Additionally, two stemness subtypes had distinct tumor immune microenvironment patterns. Tumor Immune Dysfunction and Exclusion and subclass mapping analysis further demonstrated patients in Stemness Subtype I were more likely to respond to immunotherapy, especially anti-PD1 treatment. The pRRophetic algorithm also indicated patients in Stemness Subtype I were more resistant to temozolomide therapy. Finally, multiple machine learning algorithms were used to develop a 7-gene Stemness Subtype Predictor, which were further validated in two external independent GBM cohorts. This novel stemness-based classification could provide a promising prognostic predictor for GBM and may guide physicians in selecting potential responders for preferential use of immunotherapy.

1 January 2014 in International Journal of Biological Sciences
Verified
Journal Article
Open access
BNBin Ning
Bin Ning
LGLu Gao
Lu Gao
RLRong-Han Liu
Rong-Han Liu
YLYang Liu
Yang Liu
NZNa-Sha Zhang
Na-Sha Zhang
ZCZhe-Yu Chen
Zhe-Yu Chen
MicroRNAs (miRNAs) are a novel class of small non-coding RNAs that negatively regulate gene expression at the post-transcriptional level. miRNAs can modulate gene expression and thus play important roles in diverse neurobiological processes, such as cell differentiation, growth, proliferation and neural activity, as well as the pathogenic processes of spinal cord injury (SCI) like inflammation, oxidation, demyelination and apoptosis. Results from animal studies have revealed the temporal alterations in the expression of a large set of miRNAs following SCI in adult rats, and the expressional changes in miRNAs following SCI is bidirectional (increase or decrease). In addition, several miRNAs have distinct roles in prognosis of SCI (protective, detrimental and varied). Taken together, the existing evidence suggests that abnormal miRNA expression following SCI contributes to the pathogenesis of SCI, and miRNAs may become potential targets for the therapy of SCI.

17 December 2019 in Aging
Verified
Journal Article
Open access
ZWZihao Wang
Zihao Wang
LGLu Gao
Lu Gao
Xiaopeng GuoXiaopeng Guo
Xiaopeng Guo
CFChenzhe Feng
Chenzhe Feng
WLWei Lian
Wei Lian
BXBing Xing
Bing Xing
Glioblastoma (GBM) is the most common brain tumor with significant morbidity and mortality. Autophagy plays a vital role in GBM development and progression. We aimed to establish an autophagy-related multigene expression signature for individualized prognosis prediction in patients with GBM. Differentially expressed autophagy-related genes (DE-ATGs) in GBM and normal samples were screened using TCGA. Univariate and multivariate Cox regression analyses were performed on DE-ATGs to identify the optimal prognosis-related genes. Consequently, NRG1 (HR=1.142, P=0.008), ITGA3 (HR=1.149, P=0.043), and MAP1LC3A (HR=1.308, P=0.014) were selected to establish the prognostic risk score model and validated in the CGGA validation cohort. GSEA revealed that these genes were mainly enriched in cancer- and autophagy-related KEGG pathways. Kaplan-Meier survival analysis demonstrated that patients with high risk scores had significantly poorer overall survival (OS, log-rank P= 6.955×10-5). The autophagy signature was identified as an independent prognostic factor. Finally, a prognostic nomogram including the autophagy signature, age, pharmacotherapy, radiotherapy, and IDH mutation status was constructed, and TCGA/CGGA-based calibration plots indicated its excellent predictive performance. The autophagy-related three-gene risk score model could be a prognostic biomarker and suggest therapeutic targets for GBM. The prognostic nomogram could assist individualized survival prediction and improve treatment strategies.

30 September 2016 in Pituitary
Verified
Journal Article
Closed access
PDF file
LGLu Gao
Lu Gao
Xiaopeng GuoXiaopeng Guo
Xiaopeng Guo
RTRui Tian
Rui Tian
QWQiang Wang
Qiang Wang
MFMing Feng
Ming Feng
BXBing Xing
Bing Xing

14 January 2019 in Pituitary
Verified
Journal Article
Closed access
PDF file
YWYanyan Wu
Yanyan Wu
LGLu Gao
Lu Gao
Xiaopeng GuoXiaopeng Guo
Xiaopeng Guo
ZWZihao Wang
Zihao Wang
WLWei Lian
Wei Lian
HZHuijuan Zhu
Huijuan Zhu

1 June 2018 in World Neurosurgery
Verified
Journal Article
Closed access
ZWZihao Wang
Zihao Wang
LGLu Gao
Lu Gao
XZXiaoyu Zhou
Xiaoyu Zhou
Xiaopeng GuoXiaopeng Guo
Xiaopeng Guo
QWQiang Wang
Qiang Wang
BXBing Xing
Bing Xing